Compounded Semaglutide, Explained in Plain Words
Compounded semaglutide is the pharmacy prepared version of the active ingredient in Ozempic and Wegovy, advertised from about $249 a month. It is not FDA approved, and the rules around it tightened after the FDA declared the semaglutide shortage over. This page explains what it is, the cautions regulators publish, and how to judge a pharmacy offering it.
What compounded means
Compounding is the long standing pharmacy practice of preparing a medicine for an individual patient, based on a prescription, rather than supplying a factory made product. A prescriber writes the prescription, a compounding pharmacy prepares the product, and the patient receives something made for them rather than a sealed branded pen. Compounded semaglutide uses the same active ingredient name as Ozempic and Wegovy, but the finished product is prepared by the pharmacy, and it is not FDA approved: the FDA has not reviewed that product for safety, effectiveness or manufacturing quality.
503A and 503B, in plain words
503A pharmacies
A 503A pharmacy is the traditional compounding pharmacy. It is licensed and overseen mainly by its state board of pharmacy, and it prepares medicines for individual patients against their prescriptions. This is the category most compounded GLP-1 products come from.
503B outsourcing facilities
A 503B outsourcing facility registers with the FDA and follows stricter federal manufacturing standards. It can prepare larger batches, including for clinics to hold in stock. The extra oversight is real, but it does not change the key point: a compounded product from either category is still not an FDA approved medicine.
Why the price is about $249 a month
The figure used on this site, about $249 a month, is a typical advertised starting price for compounded semaglutide, against an Ozempic list price of about $1,000 a month for the branded pen. The gap exists because the product, the oversight and the business model are all different. Treat the advertised figure as a starting price: the real monthly total can rise with the dose, and many services add consultation and membership fees. Ask any provider for the full monthly total at your dose before comparing. The compounded savings calculator compares the branded and compounded figures directly.
The FDA cautions
The FDA has published specific cautions about compounded GLP-1 products. It has received reports of dosing errors, because patients often measure doses themselves from a vial and concentrations differ between pharmacies. It has warned that some products use salt forms of the ingredient, such as semaglutide sodium or semaglutide acetate, which are different substances from the ingredient in the approved medicines and have not been shown to be safe or effective. It has also warned about counterfeit products sold through illegitimate online sellers. None of these warnings means every compounded product is bad; together they mean the buyer carries checks that a branded pen makes unnecessary.
How the legal ground shifted
For a period, semaglutide was on the FDA's drug shortage list, and during a shortage the rules allow compounding pharmacies broader room to prepare copies of a commercially available medicine. The FDA has since declared the shortage over, and the rules tightened accordingly: outside shortage conditions and individual patient needs, compounding what amounts to a copy of a commercially available drug is restricted. The position can keep evolving through FDA decisions and court cases, so treat any provider's claim about legality as something to check against the FDA's current published position, not as a settled sales point.
How to evaluate a compounding pharmacy
- A prescription is required. If a seller will supply without one, stop there.
- The pharmacy is licensed in your state. State boards of pharmacy publish license lookups; a legitimate pharmacy expects you to check.
- The ingredient is named plainly. The paperwork should say semaglutide, not a salt form such as semaglutide sodium or semaglutide acetate.
- Concentration and dosing are written clearly. Most dosing errors happen at the syringe, so instructions should be unambiguous, with a pharmacist you can contact.
- 503B registration, where claimed, checks out. Outsourcing facilities appear on the FDA's public register.
Dosing is not the branded pen schedule
Branded pens deliver fixed doses in clicks and set steps, and the semaglutide dosage chart shows that schedule. Compounded products do not follow it: they arrive as vials at pharmacy specific concentrations, and doses are measured by volume or syringe units. Never convert a pen dose to a vial dose by yourself, and never borrow conversion advice from a forum. The number your pharmacy writes on your prescription is the only conversion that applies to you. The cheapest GLP-1 without insurance ranking sets this product in the full price picture.
Frequently asked questions
Is compounded semaglutide the same as Ozempic?
It carries the same active ingredient name, semaglutide, but it is not the same product. Ozempic is an FDA approved, factory made pen with a fixed dosing system. Compounded semaglutide is prepared by a pharmacy for an individual prescription, is not FDA approved, and its strength and dosing depend on the pharmacy's preparation and instructions.
Is compounded semaglutide legal?
It depends on current federal and state rules and on the pharmacy's status. Compounding is a long standing legal practice for individual patient needs, but the broad supply of copies of branded GLP-1 medicines was tied to the FDA shortage list, and the rules tightened when the FDA declared the shortage over. A valid prescription and a state licensed pharmacy are required either way. Check the FDA's current position before relying on a provider's claims.
Why is compounded semaglutide advertised at about $249 a month?
That figure is a typical advertised starting price, not a regulated list price. It reflects a pharmacy prepared product without the branded manufacturer's pricing structure, and the real monthly total can rise with dose, consultation fees and program charges. Ask any provider for the full monthly total at your dose before comparing it with anything.
What is the difference between a 503A and a 503B pharmacy?
A 503A pharmacy is a traditional compounding pharmacy, regulated mainly by its state board, that prepares medicines for individual patients with prescriptions. A 503B outsourcing facility registers with the FDA, follows stricter manufacturing standards and can prepare larger batches. Products from both are compounded, which means the finished product is not FDA approved.
What are the main risks of compounded semaglutide?
The FDA has published cautions covering dosing errors, because doses are often measured by the patient from a vial; salt forms such as semaglutide sodium, which are not the approved ingredient; and counterfeit products sold online. There is also no FDA review of the compounded product's safety or effectiveness. A licensed pharmacy, a real prescription and clear dosing instructions reduce these risks but do not remove them.